147 related articles for article (PubMed ID: 21499441)
1. Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.
Nalabothula N; Chakravarty D; Pierce A; Carrier F
Mol Cell Pharmacol; 2010; 2(5):179-189. PubMed ID: 21499441
[TBL] [Abstract][Full Text] [Related]
2. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by RITA treatment.
Wolfová K; Otevřelová P; Holoubek A; Brodská B
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin sets a threshold for p53 response to UV radiation.
Maiguel DA; Jones L; Chakravarty D; Yang C; Carrier F
Mol Cell Biol; 2004 May; 24(9):3703-11. PubMed ID: 15082766
[TBL] [Abstract][Full Text] [Related]
4. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
5. Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.
Li J; Sejas DP; Burma S; Chen DJ; Pang Q
Carcinogenesis; 2007 Jun; 28(6):1163-70. PubMed ID: 17277230
[TBL] [Abstract][Full Text] [Related]
6. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
7. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.
Tominaga K; Morisaki H; Kaneko Y; Fujimoto A; Tanaka T; Ohtsubo M; Hirai M; Okayama H; Ikeda K; Nakanishi M
J Biol Chem; 1999 Oct; 274(44):31463-7. PubMed ID: 10531348
[TBL] [Abstract][Full Text] [Related]
8. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
[TBL] [Abstract][Full Text] [Related]
9. Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization.
Kaufmann WK; Campbell CB; Simpson DA; Deming PB; Filatov L; Galloway DA; Zhao XJ; Creighton AM; Downes CS
Cell Cycle; 2002; 1(3):210-9. PubMed ID: 12429935
[TBL] [Abstract][Full Text] [Related]
10. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
[TBL] [Abstract][Full Text] [Related]
11. Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules RS; Levedakou EN; Wilson SJ; Innes CL; Rhodes N; Tlsty TD; Galloway DA; Donehower LA; Tainsky MA; Kaufmann WK
Cancer Res; 1995 Apr; 55(8):1763-73. PubMed ID: 7712486
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin Protein Dephosphorylation by DUSP3 Is a Fine-Tuning Regulator of p53 Signaling to Maintain Genomic Stability.
Russo LC; Ferruzo PYM; Forti FL
Front Cell Dev Biol; 2021; 9():624933. PubMed ID: 33777934
[TBL] [Abstract][Full Text] [Related]
13. BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation.
Wei F; Ojo D; Lin X; Wong N; He L; Yan J; Xu S; Major P; Tang D
Oncogene; 2015 Jun; 34(23):3063-75. PubMed ID: 25088203
[TBL] [Abstract][Full Text] [Related]
14. Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.
Bower JJ; Zhou Y; Zhou T; Simpson DA; Arlander SJ; Paules RS; Cordeiro-Stone M; Kaufmann WK
Cell Cycle; 2010 Apr; 9(8):1617-28. PubMed ID: 20372057
[TBL] [Abstract][Full Text] [Related]
15. AML-associated mutation of nucleophosmin compromises its interaction with nucleolin.
Šašinková M; Holoubek A; Otevřelová P; Kuželová K; Brodská B
Int J Biochem Cell Biol; 2018 Oct; 103():65-73. PubMed ID: 30130654
[TBL] [Abstract][Full Text] [Related]
16. Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: implications for evaluation of clinical radiosensitivity.
Mirzayans R; Severin D; Murray D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1498-505. PubMed ID: 17126209
[TBL] [Abstract][Full Text] [Related]
17. Defective p53 response and apoptosis associated with an ataxia-telangiectasia-like phenotype.
Gueven N; Becherel OJ; Birrell G; Chen P; DelSal G; Carney JP; Grattan-Smith P; Lavin MF
Cancer Res; 2006 Mar; 66(6):2907-12. PubMed ID: 16540636
[TBL] [Abstract][Full Text] [Related]
18. Growth of persistent foci of DNA damage checkpoint factors is essential for amplification of G1 checkpoint signaling.
Yamauchi M; Oka Y; Yamamoto M; Niimura K; Uchida M; Kodama S; Watanabe M; Sekine I; Yamashita S; Suzuki K
DNA Repair (Amst); 2008 Mar; 7(3):405-17. PubMed ID: 18248856
[TBL] [Abstract][Full Text] [Related]
19. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.
Mukhopadhyay UK; Senderowicz AM; Ferbeyre G
Cancer Res; 2005 Apr; 65(7):2872-81. PubMed ID: 15805289
[TBL] [Abstract][Full Text] [Related]
20. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.
Nakagawa K; Taya Y; Tamai K; Yamaizumi M
Mol Cell Biol; 1999 Apr; 19(4):2828-34. PubMed ID: 10082548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]